EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study

Ajay Thomas Alex iD, Sean P Hassan, Helen Benghiat, Liam Herbert, Jennifer Adamski, Shivani Bailey, Claire Esler, Louise Brookes, Molly Bamber, Grace Koudou, Karen Waite, Julie Bennett und 2 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70498 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Ajay Thomas Alex und 13 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: Re-Irradiation, Glioma, Brain Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Children with recurrent diffuse midline gliomas (DMGs) have limited therapeutic options at recurrence. Re‐irradiation (RT2) may be used at progression, but with uncertainty about the benefit.

Methods

We conducted a multi‐institutional retrospective study of children aged < 18 with DMG treated at three centers (Toronto, Canada; Birmingham, UK; Nottingham, UK). Patients with radiologic progression after the first radiation (RT1) were included. Overall survival (OS) was calculated from the date of progression after RT1. Survival was analyzed using the Kaplan–Meier method. Multivariable Cox regression identified independent predictors of OS.

Results

A total of 167 patients were included with a median age of 7.9 years; 54 (32%) received RT2. Children selected for RT2 had a longer interval from RT1 to progression (0.79 vs. 0.52 years, p < 0.0001). Median OS from progression was longer in the RT2 group (0.59 years) compared to the no RT2 cohort (0.21 years; p < 0.0001). Six‐month OS was 68% versus 16%, and 1‐year OS was 19% versus 3%, respectively. Patients needing RT2 ≥ 1 year after RT1 had superior survival compared with earlier RT2 (0.81 vs. 0.42 years; p = 0.0041). Higher RT2 dose (≥30.6 Gy) showed a non‐significant trend towards longer OS ( p = 0.086). In multivariable analysis, use of RT2 was the strongest independent predictor of survival (HR 0.29, 95% CI 0.20–0.42; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Re-IrradiationGliomaBrain NeoplasmsNeoplasm Recurrence, LocalHumansFemaleRetrospective StudiesMaleChildChild, PreschoolAdolescentSurvival RateFollow-Up StudiesInfantPrognosis

Stichwörter der Autor:innen

diffuse midline gliomaneuro‐oncologypediatricre‐irradiation

Autor:innen und Institutionen

  • Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Canada.
  • Department of Oncology, Division of Radiation Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Hall-Edwards Radiotherapy Research Group, Queen Elizabeth Hospital, Birmingham, UK.
  • Division of Pediatric Neuro-Oncology, Birmingham Children Hospital, Birmingham, UK.
  • Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.

ORCID-Profile: Ajay Thomas Alex, Derek S Tsang

Zitieren

APA

Alex, A. T., Hassan, S. P., Benghiat, H., Herbert, L., Adamski, J., Bailey, S., Esler, C., Brookes, L., Bamber, M., Koudou, G., Waite, K., Bennett, J., Das, A., & Tsang, D. S. (2026). Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70498

Vancouver

Alex AT, Hassan SP, Benghiat H, Herbert L, Adamski J, Bailey S, et al. Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70498

BibTeX
@article{Alex2026,
  author = {Alex, Ajay Thomas and Hassan, Sean P and Benghiat, Helen and Herbert, Liam and Adamski, Jennifer and Bailey, Shivani and Esler, Claire and Brookes, Louise and Bamber, Molly and Koudou, Grace and Waite, Karen and Bennett, Julie and Das, Anirban and Tsang, Derek S},
  title = {Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70498}
}
Kostenlos starten →